DermTech Financials

DermTech Stock Summary

DermTech competes with TransMedics, Curiositystream, Fulgent Genetics, Outset Medical, and Clearpoint Neuro. DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. The company sells its products primarily to pathology and oncology practitioners. Dermtech operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 255 people.

DermTech Key Financial Ratios

DermTech Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining DermTech's current stock value. Our valuation model uses many indicators to compare DermTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DermTech competition to find correlations between indicators driving DermTech's intrinsic value. More Info.DermTech is rated # 3 in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value DermTech by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

DermTech Market Pulse

Along with financial statement analysis, the daily predictive indicators of DermTech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of DermTech. We use our internally-developed statistical techniques to arrive at the intrinsic value of DermTech based on widely used predictive technical indicators. In general, we focus on analyzing DermTech Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build DermTech's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

If you are still planning to invest in DermTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DermTech's history and understand the potential risks before investing.